Biologistics Strategy for Scale-Up 2019

Supply Chain

Biologistics Strategy for Scale-Up 2019

Biologistics Strategy for Scale-Up 2019

Filter by ContentType

Mitigating raw materials risk during preclinical-clinical transitioning

Mitigating raw materials risk during preclinical-clinical transitioning

Adam Hostetler, Gerry Maybach
09 December 2019
Interview
 Critical needs and challenges for the cell and gene therapy raw materials supply chain

Critical needs and challenges for the cell and gene therapy raw materials supply chain

S Baila, M Frechette, K Francis et al
25 November 2019
Expert Roundtable
 Expert Roundtable: Critical needs & challenges for the cell & gene therapy raw materials supply chain

Expert Roundtable: Critical needs & challenges for the cell & gene therapy raw materials supply chain

S Baila, M Frechette, D Goel et al
11 November 2019
Expert Roundtable Video
 Process development considerations for cryopreservation of cellular therapies

Process development considerations for cryopreservation of cellular therapies

Alireza Abazari
11 November 2019
Innovator Insight
 Mitigating risk in the gene therapy supply chain

Mitigating risk in the gene therapy supply chain

Chad Presher
04 November 2019
Interview
 Preparing a patient-specific cellular immunotherapy supply chain for commercialisation

Preparing a patient-specific cellular immunotherapy supply chain for commercialisation

Dirk De Naeyer
03 November 2019
Interview

Other editions


<< Back to Supply Chain channel